Skip to content

Netherlands Obstetric Surveillance System

Netherlands Obstetric Surveillance System

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON22753
Enrollment
100
Registered
2013-09-05
Start date
2013-09-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eclampsia

Interventions

none. Since this is an national observational study, there are no interventions applicable.

Sponsors

Leids University Medical Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Eclampsia: Any woman with convulsion(s) during pregnancy or in the first 10 days postpartum, not attributable to other causes. Cardiac arrest: Any pregnant women in the Netherlands identified as receiving basic life support (chest compressions and, where possible, ventilation breaths), including women who have undergone PMCS. Amniotic fluid embolism: IN THE ABSENCE OF ANY OTHER CLEAR CAUSE Either: Acute maternal collapse with one or more of the following features: • Acute fetal compromise • Cardiac arrest • Cardiac rhythm problems • Coagulopathy • Hypotension • Maternal hemorrhage* • Premonitory symptoms (restlessness, numbness, agitation, tingling) • Seizure • Shortness of breath * Excluding women with maternal haemorrhage as the first presenting feature in whom there was no evidence of early coagulopathy or cardio-respiratory compromise Or Women in whom the diagnosis was made at post-mortem examination with the finding of fetal squames or hair in the lungs Control group: For every case of eclampsia, a matching control will be retriewed from the reporting hospital. Controls will be retriewed by using the hospital registrtion of deliveries. Controls a matched only of parity.

Exclusion criteria

Exclusion criteria: Not meeting inclusion criteria.

Design outcomes

Primary

MeasureTime frame
Incidence All variables will be ascertained from anonymised photocopies from case-files and entered in a secured database. Incidence will be calculated using the CBS data on deliveries per anum.

Secondary

MeasureTime frame
Putative risk factors, differences in management stratagies. By using the control group analysis of different management stratagies will be performed.

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)